ES-SCLCsmall cell lung cancertarlatamabatezolizumabdurvalumabMerck Sharp & Dohme LLCcarboplatin
…ons This study showed that while more than 70% of patients with ES-SCLC received ICI-containing regimens as first-line treatment, progn…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 2,521–2,580 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Acute upper gastrointestinal bleeding3Advanced Prostate Cancer3Advanced chronic kidney disease3Alcohol-related liver disease (ArLD)3Allergic Bronchopulmonary Aspergillosis3Amyloid Beta-Related Angiitis3Anterior cruciate ligament reconstruction (ACLR)3Antiphospholipid syndrome (APS)3Appendiceal cancer3Arteriovenous malformation3Atherosclerotic plaque3B-cell lymphomas3B16 melanoma3Barrett’s oesophagus (BO)3Blood blister-like aneurysms3Budd Chiari Syndrome3CCS3CMDs3Cancer-related fatigue3Cardiovascular3Cerebral arteriovenous malformations3Cerebral venous sinus thrombosis (CVST)3Cerebral venous thrombosis3Chronic Inflammatory Demyelinating Polyradiculoneuropathy3Chronic Renal Failure3Chronic hepatitis B virus (HBV) infection3Chronic hypercapnic respiratory failure3Climate change3Common bile duct (CBD) stones3Complex PTSD3Congenital Heart Diseases3Cryptococcus neoformans3Cutaneous squamous cell carcinoma (CSCC)3Cutaneous tuberculosis3DIPG3Diabetes mellitus type 23Diabetic ketoacidosis (DKA)3Diabetic peripheral neuropathy3Diffuse intrinsic pontine glioma (DIPG)3Digital ulcers (DUs)3Discoid lupus3Disorders of gut–brain interaction (DGBI)3Dry age-related macular degeneration3Dry eye disease (DED)3EBS3ECS3Echinococcus granulosus3End-stage kidney disease (ESKD)3Endocrinopathy3Epidermolysis Bullosa3Epidural hematoma3Esophageal atresia3F4 fibrosis3Facioscapulohumeral Dystrophy3Familial haemophagocytic lymphohistiocytosis3Fetal alcohol spectrum disorder3Fibrolamellar carcinoma (FLC)3Fontan-associated liver disease3Frontotemporal lobar degeneration3GBM-bearing3
Articles mentioning diseases
23,712 articles · page 273 of 1976Merkel cell carcinomacutaneous malignancymelanomasquamous cell carcinomacutaneous malignanciessirolimusInova Schar Cancer Instituteeverolimusprednisonemycophenolate+4 more
…gnancies including melanoma, squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC). However, the concurrent use of ICIs and immunosuppressan…
93.5%
AMLAcute myeloid leukemiaES038LILRB4
…es NK cell activation and improves their therapeutic potential. AML, particularly in relapsed or refractory cases, remains a signif…
metastatic castration-resistant prostate cancermCRPCpancreatic ductal carcinomaprostate canceripilimumabenzalutamideJ Clin OncolAtezolizumab
…al. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nat Med. 2022;28:144–53.Koo KC, Pa…
CRSOCrecurrent advanced OCsarilumabubamatamab
…4.Conclusions A single sarilumab dose before ubamatamab reduced CRS incidence and severity. Pharmacokinetic and pharmacodynamic fin…
head and neck squamous cell carcinomaadvanced solid tumorsHNSCCCHS-114
…ansion study is evaluating CHS-114 in advanced solid tumors and head and neck squamous cell carcinoma (HNSCC). CHS-114 has demonstrated an acceptable safety profile …
MelanomaNSCLCImneskibartAvelumab
…or regressions and a low incidence of Grade 3/4 adverse events. Melanoma patients with primary resistance to prior doublet immune checkp…
neuroblastomasolid tumorshematological malignanciesSK-N-ASNB[67Cu]Cu-LLP2A[ 67Cu]Cu-LLP2A67Cu]Cu-LLP2ANIH institutional IACUCRPT
…ell therapy remains less effective against solid tumors such as neuroblastoma (NB) than hematological malignancies. Key obstacles for CAR T c…
melanoma-specificExtramammary Paget’s disease (EMPD)EMPDmelanomasolid tumorsEBV-related cancersIL-2Radiother OncolAdoptive CTL therapyProc Natl Acad Sci USA+1 more
…:62-68.Chapuis AG, Ragnarsson GB, Nguyen HN, et al. Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire cen…
NSCLCnon-small cell lung cancerA375 melanomaNSCLC-bearingcisplatincarboplatincisplatin-inducedcisplatin-treatedPEG-ADA
… NSCLC cells. For T cell suppression assays, M-MDSCs from human NSCLC were cultured with autologous T cells stimulated with anti-CD3 …
melanomamicrosatellite instability-high (MSI-H) tumorsUniversity of MichiganImmune checkpoint inhibitorsICIsfirst-line immunotherapy
…reatment, toxicity, and fertility characteristics of young male melanoma patients treated with immune checkpoint inhibitors (n=38)…
Melanomamyelodysplastic syndromestherapy-related myeloid neoplasmsimmune checkpoint inhibitorsimmune checkpoint inhibitor therapyEmbasePubMedScopus
…rrow niche alterations and hematopoietic clonal dynamicsResults Melanoma tumor cells infiltrate the bone marrow early, with disseminated…